Hypericum Treatment of Mild Depressions with Somatic Symptoms

Abstract

In a randomized, placebo-controlled, double-blind study, 39 patients with depression with somatic symptoms were treated with hypericum extract LI 160. The therapy lasted for 4 weeks; the dosage was 300 mg three times daily. At the onset of the study as well as after 2 and 4 weeks, the following criteria were analyzed: HAMD, B-L, CGI, and vegetative symptoms. The results show a significant improvement in the active treatment group at the 5% level as compared to placebo. Seventy percent of the patients treated with LI 160 were free of symptoms after 4 weeks. Typical symptoms of the depression such as lack of activity, tiredness, fatigue, and disturbed sleep, were especially responsive. In no case were any undesirable side effects observed.

Get full access to this article

View all access options for this article.

References

Degkwitz

, Helmchen

, Kockhoff

, Mombour

Diagnosenschlüssel und Glossar psychiatrischer Krankheiten. Berlin: Springer-Verlag, 1980.

Hamilton

049 HAMD. Hamilton Depressions Scale. In: Guy

, ed. ECDEU assessment manual for psychopharmacology. Rev Ed. Rockville, MD: 1976: 179–192.

Zerssen

D v

. Die Beschwerden-Liste als Test. Therapiewoche 1971; 21: 1908–1914.

National Institute of Mental Health 028 CGI. Clinical Global Impressions. In: Guy

, ed. ECDEU assessment manual for psychopharmacology. Rev Ed. Rockville, MD: 1976: 217–222.

Halama

Wirksamkeit des Johanniskrautextraktes LI 160 bei depressiver Verstimmung.

Nervenheilkunde 1991; 10: 250–253.

Hänsgen

K-D

, Vesper

, Ploch

Mutizentrische Doppel-blindstudie zur antidepressiven Wirksamkeit des Hypericum Extraktes LI 160.

Nervenheilkunde 1993; 12: 285–289. Translated in: Hänsgen K-D, Vesper J, Ploch M. Multicenter double-blind study examining the antidepressant effectiveness of the hypericum extract LI 160. J Geriatr Psychiatry Neurol 1994; 7(suppl 1): S15–S18.

Harrer

, Hübner

W-D

, Podzuweit

Wirksamkeit und Verträglichkeit des Hypericum-Prparates LI 160 im Vergleich mit Maprotilin.

Nervenheilkunde 1993; 12: 297–301. Translated in: Harrer G, Hübner W-D, Podzuweit H. Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline: a multicenter double-blind study. J Geriatr Psychiatry Neurol 1994; 7(suppl 1): S24–S28.

Vorbach

E-U

, Hübner

W-D

, Arnoldt

Wirksamkeit und Verträglichkeit des Hypericum-Extraktes LI 160 im Vergleich mit Imipramin.

Nervenheilkunde 1993; 12: 290–296. Translated in: Vorbach E-U, Hübner W-D, Arnoldt K. Effectiveness and tolerance of the hypericum extract LI 160 in comparison with imipramine: randomized double-blind study with 135 outpatients. J Geriatr Psychiatry Neurol 1994; 7(suppl 1): S19–S23.

Johnson

, Siebenhüber

, Hofer

Einfluβ von Johanniskraut auf die ZNS-Aktivität.

Neurol Psychiatr 1992. 6: 436–444.

10.

Johnson

, Ksciuk

, Woelk

Wirkungen von Johanniskraut-Extrakt LI 160 im Vergleich mit Maprotilin auf Ruhe-EEG und evozierte Potentiale bei 24 Probanden.

Nervenheilkunde 1993; 12: 328–330. Translated in: Johnson D, Ksciuk H, Woelk H, et al. Effects of hypericum extract LI 160 compared with maprotiline on resting EEG and evoked potentials in 24 volunteers. J Geriatr Psychiatry Neurol 1994; 7(suppl 1): S44–S46.

11.

Schulz

, Jobert

Der Einfluβ von Johanniskrautextrakt auf das Schlaf-EEG bei älteren Probandinnen.

Nervenheilkunde 1993; 12: 323–327. Translated in: Schulz H, Jobert M. Effects of hypericum extract on the sleep EEG in older volunteer. J Geriatr Psychiatry Neurol 1994; 7(suppl 1): S39–S43.